Skip to main content
. 2023 Dec 1;13:119. doi: 10.1186/s13613-023-01216-8

Table 2.

Univariate and multivariate analysis of factors associated with acute kidney injury meeting the criteria for the stage 3 of the KDIGO classification

Univariate analysis Multivariate analysis
OR IC 95% p OR IC 95% p
DIC 3.12 1.99–4.91  < 0.001 2.74 1.53–4.91  < 0.001
Age (per 1-year increment) 1.0 0.99–1.02 0.645 0.97 0.95–0.99 0.011
Male sex 0.96 0.62–1.50 0.865
SAPS II (per 1pt increment) 1.06 1.05–1.08  < 0.001 1.06 1.04–1.07  < 0.001
SOFA (per 1pt increment) 1.44 1.31–1.57  < 0.001
Chronic hypertension 1.80 1.16–2.81 0.009 1.75 0.95–3.20 0.071
Diabetes 1.56 0.98–2.48 0.059 1.41 0.77–2.60 0.265
Chronic heart failure 1.35 0.58–3.16 0.483
CKD 1.78 0.97–3.26 0.063 2.42 1.03–5.68 0.043
Liver cirrhosis 2.71 0.89–8.27 0.079 1.00 0.26–3.91 0.996
Cancer 0.68 0.38–1.22 0.194 0.52 0.25–1.11 0.091
COPD 0.82 0.47–1.42 0.475
Source of infection
 Lung 1.15 0.74–1.80 0.532
 Abdominal 1.77 0.99–3.19 0.056 1.66 0.80–3.43 0.175
 Urinary tract 0.90 0.53–1.53 0.703
 Bloodstream infection 0.79 0.48–1.29 0.349
 Nosocomial infection 0.78 0.36–1.68 0.525
 Immunosuppression 1.13 0.58–2.22 0.713
 Cocci gram positive 0.78 0.49–1.22 0.269 -
 Bacillus gram negative 1.49 0.97–2.28 0.071 1.47 0.86–2. 45 0.161
Organ-support at inclusion
 Epinephrine 6.06 2.67–13.73  < 0.001 1.99 0.71–5.55 0.187
 Dobutamine 1.71 1.00–2.92 0.052 1.28 0.63–2.59 0.494
 Norepinephrine > 1 µg/kg/min at day 1 3.18 1.99–5.07  < 0.001 1.31 0.72–2.39 0.372
 Fluid before inclusion > 1L 5.57 1.21–17.18 0.025 4.34 0.82–23.1 0.085
 Invasive mechanical ventilation 5.13 2.11–12.50  < 0.001 2.50 0.86–7.27 0.092
 Nephrotoxic drugs, yes 0.52 0.19–1.43 0.207 0.77 0.18–3.23 0.724
 Nephrotoxic drugs 1.06 0.89–1.25 0.514

Bolditalic characters were proposed to illustrate values who reached statistical significancy, i.e. p < 0.05

CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DIC, disseminated intravascular coagulation; OR, odds ratio; SAPS II, Simplified Acute Physiologic Score II; SOFA, Sequential Organ Failure Assessment